ATYR PHARMA INC
ATYRNASDAQ🏆 #4009 by market capEarnings Nov 5US Equity
$0.54▲ $0.01 (+1.70%)
Live1h▲ 0.5%
24h▲ 1.7%
7d▲ 4.6%
14d▲ 13.2%
30d▲ 7.5%
1y▼ 89.6%
🏦Market Cap
$53M
Small Cap
📈Revenue Growth (YoY)
-19.1%
Declining
📊Gross Margin
-11754.7%
Thin
💵FCF Margin
-28852.1%
Thin
⚖️P/S Ratio
279.2x
Expensive
Otter Score
67
Fair
📊
Analyst Ratings
Price
$0.5431
Total
10
Raised
1
Lowered
6
Avg PT
$5.13
H / L
$17 / $1
| Institution | Action | Rating | Date |
|---|---|---|---|
Freedom Broker | Upgraded | Hold → Buy | 2026-05-20 |
RBC Capital | Reiterated | Sector Perform | 2025-11-07 |
Wells Fargo | Downgraded | Overweight → Equal Weight | 2025-09-16 |
LUCID CAPITAL MARKETS | Downgraded | Buy → Neutral | 2025-09-15 |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-09-15 |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2025-09-15 |
Jones Trading | Downgraded | Buy → Hold | 2025-09-15 |
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2025-09-15 |
Jefferies | Reiterated | Buy | 2025-08-22 |
HC Wainwright& Co. | Reiterated | Buy | 2024-05-03 |
One row per institution, most recent rating